-- Sego Resources (SGZ.V) 周一宣布，已在不列颠哥伦比亚省的 Miner Mountain 项目启动一项三孔、总钻探深度 2000 米的钻探计划。 该公司表示，钻探工作从 Cuba 矿区北部开始，旨在穿越 Quintana 2009 Titan 24 反向极化率异常区。该公司还补充说，2013 年的冲击钻探计划发现了浸染状黄铁矿、绢云母-绿泥石-碳酸盐蚀变组合，并检测到少量铜矿。 计划在南部金矿带区域钻探两个钻孔，并在南部金矿带北部钻探一个深斜孔。该区域的铜金矿化以及地表零星的土壤铜金矿化可能代表斑岩型矿化，这与2009年地球物理勘探中发现的200至300米深的反演极化率异常相符。 该公司表示，计划增设IP测线，以完善2009年的勘探范围，并将勘探范围向2009年勘探范围边缘反演极化率异常的南部和西部延伸。 “计划在南部金矿带东部钻探一个浅孔，以测试地表发现的铜金矿化下方的情况。此外，在由Climax Copper Co.钻探的64米AX钻孔（~1.2英寸）末端，发现了厚度超过14米的、含量为几个百分点的浸染状黄铁矿。”该公司补充道：“该矿石于1963年开采，但未进行铜或金的分析。” 该公司股票最后一次交易是在4月22日，在多伦多证券交易所创业板收于0.05美元。
Related Articles
Insider Trading
Lifestance Health Group Insider Sold Shares Worth $492,400, According to a Recent SEC Filing
Robert Bessler, Director, on April 23, 2026, sold 69,899 shares in Lifestance Health Group (LFST) for $492,400. Following the Form 4 filing with the SEC, Bessler has control over a total of 1,485,228 common shares of the company, with 57,619 shares held directly and 1,427,609 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1845257/000119312526182153/xslF345X05/ownership.xml
$LFST
Australia
Celestica Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set
Celestica (CLS) reported Q1 adjusted earnings late Monday of $2.16 per diluted share, up from $1.20 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended March 31 was $4.05 billion, up from $2.65 billion a year earlier.Analysts surveyed by FactSet expected $4.04 billion.For Q2, the company expects adjusted EPS of $2.14 to $2.34 on revenue of $4.15 billion to $4.45 billion. Analysts expect EPS of $2.13 on revenue of $4.17 billion.The company now expects 2026 adjusted EPS of $10.15 on revenue of $19 billion, revised from $8.75 and $17 billion, respectively, expected earlier. Analysts expect EPS of $8.93 on revenue of $17.34 billion.
$CLS
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of Ameriprise Financial, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our 12-month target price of $550, valuing AMP shares at 12.5x our 2026 adjusted EPS estimate of $43.84 (raised by $1.34) and at 11.7x our 2027 EPS estimate of $46.90 (raised by $0.70). This compares to the three-year average forward multiple of 12x and peer average of 15.5x. AMP posted Q1 2026 adjusted operating EPS of $11.26 vs. $9.50, a 19% rise that topped our $10.12 estimate and $10.21 consensus view. Revenue growth of 11% exceeded our forecast and our 6%-10% growth forecast for 2026, while pretax adjusted operating margins expanded 130 bps to 28% on revenue gains and cost containment efforts. We now see revenue growth of 7% to 12% in 2026 and 2027. AMP also continued its substantial capital return program, returning $936M to shareholders in Q1 (70% of adjusted operating earnings) and $3.4B in 2025 (88% of earnings). Currently trading at 10.9x our 2026 EPS estimate, and with some decent revenue and earnings momentum, we view the shares as undervalued versus peer and historical averages.
$AMP